| +0.45 / +3.97%|
The 18 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 9.50. The median estimate represents a +1.78% increase from the last price of 11.79.
The current consensus among 21 polled investment analysts is to Hold stock in Boston Scientific Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.